Key Takeaways
- The global behavioral health market size was valued at USD 94.99 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2030, driven by rising prevalence of mental disorders and increased awareness.
- The U.S. behavioral health market was valued at USD 92.14 billion in 2023 and is projected to reach USD 132.46 billion by 2032, expanding at a CAGR of 4.1% during the forecast period from 2024 to 2032.
- The behavioral health market in North America dominated with a revenue share of 42.5% in 2023, attributed to high prevalence of mental health disorders and robust healthcare infrastructure.
- In 2021, an estimated 22.8% of U.S. adults (59.3 million people) experienced any mental illness (AMI).
- Serious mental illness (SMI) affected 6.0% of U.S. adults in 2021, equating to 15.4 million people aged 18 and older.
- Among U.S. youth aged 6-17 years, 16.5% (7.7 million) experienced a mental health disorder in 2016.
- In the past year, 48.7 million people aged 12 or older misused opioids in the U.S. (17.3% of the population).
- About 48.5 million (17.3%) people aged 12 or older misused any illicit drug in the past year in 2022.
- In 2022, 6.1 million people aged 12 or older had alcohol use disorder (AUD).
- The U.S. had 116,000 psychiatrists in 2021, with a shortage of over 30,000.
- Behavioral health workforce shortages affected 65% of U.S. rural areas in 2022.
- Only 28.4% of Americans live within 30 minutes of a mental health provider.
- In 2021, 57.8% of adults with any mental illness received treatment in the U.S.
- Federal spending on mental health and substance use services was $280 billion in FY2022.
- Only 8% of U.S. physician practices offered mental health services in 2021.
The behavioral health industry is growing significantly due to rising global demand for mental health services.
Access and Funding
- In 2021, 57.8% of adults with any mental illness received treatment in the U.S.
- Federal spending on mental health and substance use services was $280 billion in FY2022.
- Only 8% of U.S. physician practices offered mental health services in 2021.
- Medicaid covers 26% of U.S. mental health spending.
- 24% of U.S. adults with mental illness report unmet treatment needs due to cost.
- Parity laws improved access, but 20% of claims denied for behavioral health in 2022.
- SAMHSA block grants funded $2.2 billion for states in FY2023.
- 41 states cut behavioral health funding by average 2.5% in 2023.
- Telehealth mental health visits increased 150% from 2019 to 2022.
- Private insurance covers 55% of mental health expenditures in U.S.
- 1 in 4 Americans live in mental health professional shortage areas.
- Medicare behavioral health spending reached $18 billion in 2021.
- Only 50% of children with major depression receive treatment.
- State mental health agency budgets totaled $47.5 billion in FY2021.
- Out-of-pocket costs for therapy average $100-200 per session uninsured.
- 37 states expanded Medicaid coverage for substance use in 2023.
- Venture capital in digital behavioral health reached $5.5 billion in 2021.
- 65% of U.S. adults with mental illness have no insurance coverage gap issues but access barriers.
- HRSA awarded $200 million for behavioral health workforce in 2023.
- Wait times for psychiatric care average 25 days in urban U.S. areas 2023.
- Global mental health financing is less than 2% of health spending.
- U.S. opioid treatment programs received $7 billion federal funding 2022.
- 30% of behavioral health facilities accept Medicaid only partially.
- Philanthropy contributed $1.2 billion to U.S. mental health in 2022.
- Integrated care models improved access by 15% in primary care settings.
Access and Funding Interpretation
Market Size and Growth
- The global behavioral health market size was valued at USD 94.99 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2030, driven by rising prevalence of mental disorders and increased awareness.
- The U.S. behavioral health market was valued at USD 92.14 billion in 2023 and is projected to reach USD 132.46 billion by 2032, expanding at a CAGR of 4.1% during the forecast period from 2024 to 2032.
- The behavioral health market in North America dominated with a revenue share of 42.5% in 2023, attributed to high prevalence of mental health disorders and robust healthcare infrastructure.
- The global mental health apps market, a segment of behavioral health, was valued at USD 7.48 billion in 2023 and is anticipated to grow at a CAGR of 14.6% from 2024 to 2030.
- The U.S. outpatient mental health and substance abuse centers industry generated $38.7 billion in revenue in 2023, reflecting a 2.8% increase from the previous year.
- The behavioral health market in Asia Pacific is expected to register the fastest CAGR of 5.2% from 2024 to 2030, fueled by growing awareness and improving healthcare access in emerging economies.
- The crisis intervention segment of the behavioral health market accounted for 28.3% revenue share in 2023 due to increasing emergency mental health services demand.
- The global telebehavioral health market size was estimated at USD 31.60 billion in 2023 and is projected to grow at a CAGR of 20.1% from 2024 to 2030.
- In 2023, the depression segment held the largest share of 32.7% in the behavioral health market, owing to high global prevalence rates.
- The behavioral health software market reached USD 4.5 billion in 2023 and is forecasted to grow at a CAGR of 12.3% through 2030.
- Europe's behavioral health market was valued at USD 25.2 billion in 2023, with a projected CAGR of 4.5% from 2024 to 2030.
- The inpatient segment in behavioral health facilities generated $18.9 billion in U.S. revenue in 2023, up 3.2% year-over-year.
- The anxiety disorder treatment segment is expected to grow at a CAGR of 4.8% in the behavioral health market from 2024 to 2032.
- The global behavioral health market is projected to reach USD 140.2 billion by 2030, with outpatient services driving 55% of growth.
- In 2023, the substance use disorder segment accounted for 24.1% of the behavioral health market revenue globally.
- The U.S. telepsychiatry market within behavioral health was valued at $4.2 billion in 2023, growing at 25.4% CAGR.
- Latin America's behavioral health market is expected to grow at a CAGR of 4.9% from 2024 to 2030 due to rising investments.
- The EHR segment in behavioral health software market held 41% share in 2023.
- The global behavioral health market CAGR was 2.8% from 2018-2023, accelerating post-COVID.
- Residential treatment facilities in the U.S. behavioral health sector reported $12.4 billion revenue in 2023.
- The post-acute care segment in behavioral health is projected to grow at 5.1% CAGR to 2030.
- In 2023, hospitals held 35.2% share of the behavioral health service providers market.
- The behavioral health analytics market was $2.8 billion in 2023, with 18.7% CAGR forecast.
- Middle East & Africa's behavioral health market to grow at 4.3% CAGR from 2024-2030.
- The U.S. behavioral health market saw 6.2% growth in 2023 driven by insurance reimbursements.
- Cloud-based behavioral health solutions market share was 52% in 2023 globally.
- The global youth behavioral health market valued at $15.3 billion in 2023.
- Anger management segment grew 3.9% in behavioral health market in 2023.
- The behavioral health market in Canada reached CAD 12.5 billion in 2023.
- Digital therapeutics in behavioral health projected to hit $9.8 billion by 2030 at 28% CAGR.
Market Size and Growth Interpretation
Prevalence of Mental Disorders
- In 2021, an estimated 22.8% of U.S. adults (59.3 million people) experienced any mental illness (AMI).
- Serious mental illness (SMI) affected 6.0% of U.S. adults in 2021, equating to 15.4 million people aged 18 and older.
- Among U.S. youth aged 6-17 years, 16.5% (7.7 million) experienced a mental health disorder in 2016.
- Globally, 970 million people were living with a mental disorder in 2019, with anxiety and depressive disorders most common.
- In the U.S., 1 in 5 adults (20.78%) experienced mental illness in 2020.
- Depression affected an estimated 280 million people worldwide in 2019.
- Anxiety disorders affected 301 million people globally in 2019.
- In 2022, 29.4% of U.S. adults reported symptoms of anxiety or depressive disorder.
- Bipolar disorder prevalence in U.S. adults was 2.8% in 2021.
- PTSD affected 3.6% of U.S. adults in 2021.
- Among U.S. adolescents aged 12-17, 29.9% had any mental illness in 2021.
- OCD prevalence was 1.2% among U.S. adults in 2021.
- In Europe, 84 million people (38% of the population) lived with a mental health disorder in 2019.
- U.S. children aged 3-17 years had 7.7% diagnosed with anxiety in 2018-2019.
- Schizophrenia affected 1.5 million U.S. adults in 2021 (0.6% prevalence).
- Globally, 14% of adolescents aged 10-19 experience mental health conditions.
- In 2022, 5.7 million U.S. adults had serious thoughts of suicide (2.2%).
- Borderline personality disorder prevalence in U.S. was 1.6% in 2021.
- Among U.S. adults, women were more likely than men to have AMI (26.4% vs. 19.1%) in 2021.
- Eating disorders affected 9% of the global population in 2021.
- In 2021, 50.2% of U.S. adults with AMI received treatment.
- Autism spectrum disorder prevalence among U.S. 8-year-olds was 1 in 36 in 2020.
- Globally, dementia affected 55 million people in 2021.
- ADHD prevalence in U.S. children aged 3-17 was 10.5% in 2016-2019.
- In 2021, AIAN adults had the highest SMI rate at 9.1% in the U.S.
- Globally, 1 in 8 people (970 million) lived with mental disorder in 2019.
- U.S. adults aged 18-25 had 33.7% AMI prevalence in 2021.
- Conduct disorder prevalence in U.S. youth was 4.1% in 2019.
- In 2022, 12.5% of U.S. adults had serious mental illness.
- Globally, bipolar disorder affected 40 million people in 2019.
Prevalence of Mental Disorders Interpretation
Provider Workforce
- The U.S. had 116,000 psychiatrists in 2021, with a shortage of over 30,000.
- Behavioral health workforce shortages affected 65% of U.S. rural areas in 2022.
- Only 28.4% of Americans live within 30 minutes of a mental health provider.
- U.S. psychologists numbered 181,600 in 2022, projected to grow 6% by 2032.
- There were 15,800 psychiatric nurse practitioners in 2021.
- Licensed clinical social workers in mental health: 139,000 in U.S. 2022.
- Only 51% of U.S. counties had a psychiatrist in 2021.
- Global mental health workforce: 9 per 100,000 population average in 2020.
- U.S. substance abuse counselors: 120,000 employed in 2022.
- 77% of U.S. counties lack a child psychiatrist.
- Marriage and family therapists: 54,800 in U.S. 2022.
- Behavioral health tech workforce grew 12% from 2019-2022.
- In 2023, 60% of psychologists not accepting new patients due to capacity.
- U.S. peer support specialists in behavioral health: over 25,000 certified in 2022.
- Low-income countries have 0.06 psychiatrists per 100,000 people.
- Turnover rate among behavioral health providers was 27% in 2022.
- 45% of U.S. behavioral health workforce is over age 55 in 2023.
- Telehealth expanded provider reach by 40% during COVID-19.
- U.S. addiction medicine specialists: only 1,600 board-certified in 2022.
- High-income countries average 20 psychiatrists per 100,000 population.
- 1 in 3 behavioral health providers report burnout in 2023 surveys.
- Certified alcohol and drug counselors: 110,000 in U.S. 2022.
- Rural U.S. behavioral health providers per 100,000: 145 vs. 310 urban.
- Diversity: Only 5% of U.S. psychologists are Black or African American.
- Projected shortage of 195,000 behavioral health workers by 2025.
- Occupational therapists in mental health: 13% of 133,000 total in 2022.
- 68% of child psychiatrists not accepting new Medicaid patients.
- Global gap: Need 1.18 million more mental health workers.
- U.S. psychiatric NPs grew 20% from 2018-2022 to 15,800.
- In 2023, 42% of behavioral health clinics had waitlists over 2 weeks.
Provider Workforce Interpretation
Substance Use Statistics
- In the past year, 48.7 million people aged 12 or older misused opioids in the U.S. (17.3% of the population).
- About 48.5 million (17.3%) people aged 12 or older misused any illicit drug in the past year in 2022.
- In 2022, 6.1 million people aged 12 or older had alcohol use disorder (AUD).
- Marijuana was the most commonly misused illicit drug in 2022, used by 42.3 million people aged 12+.
- Heroin misuse in past year affected 828,000 people aged 12+ in 2022.
- In 2022, 2.6 million people aged 12+ had stimulant use disorder.
- Past month binge drinking was reported by 17.6% of people aged 12+ in 2022.
- Among pregnant women aged 15-44, 5.3% used illicit drugs in past month in 2022.
- 9.2 million people aged 12+ misused prescription pain relievers in past year 2022.
- Cocaine misuse affected 1.5 million people aged 12+ in past month 2022.
- Inhalant misuse in past year by 2.3 million youth aged 12-17 in 2022.
- Methamphetamine misuse by 2.7 million people aged 12+ in past year 2022.
- Nicotine dependence affected 10.3 million people aged 12+ in 2022.
- Among adults aged 18+, 29.5% reported heavy alcohol use in past month 2022.
- Opioid misuse disorder diagnosed in 6.1 million people aged 12+ in 2022.
- Hallucinogen use in past year by 3.9 million aged 12-17 youth in 2022.
- Sedative misuse affected 1.9 million aged 12+ in past year 2022.
- 70,000 U.S. drug overdose deaths occurred in 2021, 80% involving opioids.
- Alcohol contributed to 178,000 deaths annually in the U.S. (2015-2019 average).
- Tobacco use causes over 480,000 deaths yearly in the U.S.
- Past year SUD affected 20.4% of U.S. adults in 2022.
- Youth aged 12-17: 15.1% misused any substance in past year 2022.
- Fentanyl involved in 68% of opioid overdose deaths in 2021.
- Cannabis use disorder in 4.1 million aged 12+ in 2022.
- Illicit drug use past month: 24.9% among young adults 18-25 in 2022.
- Prescription tranquilizer misuse by 1.3 million aged 12+ past month 2022.
- 2.5 million adults received specialty SUD treatment in 2022.
Substance Use Statistics Interpretation
Sources & References
- Reference 1GRANDVIEWRESEARCHgrandviewresearch.comVisit source
- Reference 2FORTUNEBUSINESSINSIGHTSfortunebusinessinsights.comVisit source
- Reference 3PRECEDENCERESEARCHprecedenceresearch.comVisit source
- Reference 4IBISWORLDibisworld.comVisit source
- Reference 5MARKETSANDMARKETSmarketsandmarkets.comVisit source
- Reference 6STATISTAstatista.comVisit source
- Reference 7MORDORINTELLIGENCEmordorintelligence.comVisit source
- Reference 8NIMHnimh.nih.govVisit source
- Reference 9CDCcdc.govVisit source
- Reference 10WHOwho.intVisit source
- Reference 11NAMInami.orgVisit source
- Reference 12SAMHSAsamhsa.govVisit source
- Reference 13EUROeuro.who.intVisit source
- Reference 14NIDAnida.nih.govVisit source
- Reference 15PSYCHIATRYpsychiatry.orgVisit source
- Reference 16SHEPSCENTERshepscenter.unc.eduVisit source
- Reference 17MHANATIONALmhanational.orgVisit source
- Reference 18BLSbls.govVisit source
- Reference 19AACNNURSINGaacnnursing.orgVisit source
- Reference 20AAPaap.orgVisit source
- Reference 21BECKERSBEHAVIORALHEALTHbeckersbehavioralhealth.comVisit source
- Reference 22APAapa.orgVisit source
- Reference 23NASMHPDnasmhpd.orgVisit source
- Reference 24NCBIncbi.nlm.nih.govVisit source
- Reference 25JAMANETWORKjamanetwork.comVisit source
- Reference 26ASAMasam.orgVisit source
- Reference 27NAADACnaadac.orgVisit source
- Reference 28RURALHEALTHruralhealth.und.eduVisit source
- Reference 29MCKINSEYmckinsey.comVisit source
- Reference 30KFFkff.orgVisit source
- Reference 31HEALTHAFFAIRShealthaffairs.orgVisit source
- Reference 32CMScms.govVisit source
- Reference 33BHWbhw.hrsa.govVisit source
- Reference 34PSYCHOLOGYTODAYpsychologytoday.comVisit source
- Reference 35ROCKHEALTHrockhealth.comVisit source
- Reference 36PHILANTHROPYNEWSDIGESTphilanthropynewsdigest.orgVisit source
- Reference 37AHRQahrq.govVisit source






